#22 - Tom Dayspring, M.D., FACP, FNLA – Part III of V: HDL, reverse cholesterol transport, CETP inhibitors, and apolipoproteins
The Peter Attia Drive
00:00
Lipitology
The first failed ctep inhibiter trial was fisers back in the mid two thousand so let me give the background, and then i want you to explain why theit fail before even maybe id just sort of sprang a little more about the limpid transportatioo isgan. The h d al story is one where the more time goes on, the less i know. I mean, there are few things in lipitology that humble me more than my complete and utter buffoonery and ignorance when it comes to understanding high densely lipeaprotins. So only if you read it with that an mine, and you would see how things can we use a very specific example to
Transcript
Play full episode
